These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19720571)

  • 1. Failure to control risk factors among patients with type 2 diabetes; experience from a Greek cohort.
    Kollias A; Bliziotis IA; Xilomenos A; Tolis A
    Prim Care Diabetes; 2009 Nov; 3(4):249-52. PubMed ID: 19720571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease management of type 2 diabetes: a follow-up analysis in a sanitary district of Sicily.
    Colucci A; Bianco A; Pomara F; Petrucci M; Grosso F; De Vita A; Adamo V; Palma A
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):241-6. PubMed ID: 21769074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic risk and educational level in adult patients with type 1 diabetes.
    Nádas J; Putz Z; Fövényi J; Gaál Z; Gyimesi A; Hídvégi T; Hosszúfalusi N; Neuwirth G; Oroszlán T; Pánczél P; Vándorfi G; Winkler G; Wittmann I; Jermendy G
    Acta Diabetol; 2009 Jun; 46(2):159-62. PubMed ID: 18843447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risk factors and treatment with insulin in type II diabetic patients in whom oral hypoglycemic drugs have failed].
    Calle Pascual AL; Calle Fernández JR
    Med Clin (Barc); 1993 Jun; 101(5):165-7. PubMed ID: 8332008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update diabetes mellitus and cardiovascular diseases].
    Otter W
    MMW Fortschr Med; 2012 Apr; 154(7):95-8. PubMed ID: 22558884
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for hospitalization due to diabetes complications.
    Tomlin AM; Dovey SM; Tilyard MW
    Diabetes Res Clin Pract; 2008 May; 80(2):244-52. PubMed ID: 18243393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
    Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB
    Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 2 diabetic as cardiovascular risk patient].
    Krankenpfl J; 2005; 43(4-6):106. PubMed ID: 16171052
    [No Abstract]   [Full Text] [Related]  

  • 15. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
    Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
    Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines?
    del Cañizo-Gómez FJ; Moreira-Andrés MN
    Diabetes Res Clin Pract; 2004 Aug; 65(2):125-33. PubMed ID: 15223224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of thiazolidinedione use and cardiovascular risk: is it all about the sugar?
    Krantz MJ
    Pharmacotherapy; 2006 Jul; 26(7):1049; discussion 1049-50. PubMed ID: 16803430
    [No Abstract]   [Full Text] [Related]  

  • 18. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).
    Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diabet Med; 2011 Oct; 28(10):1213-20. PubMed ID: 21627687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
    Baldwin MD
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.